Go Pro

Myriad Genetics (MYGN) Institutional Ownership

Myriad Genetics logo
$5.82 +0.11 (+1.86%)
As of 10:58 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Myriad Genetics (NASDAQ:MYGN)

Current
Institutional Ownership
Percentage
99.02%
Number of
Institutional Buyers
(last 12 months)
132
Total
Institutional Inflows
(last 12 months)
$713.77M
Number of
Institutional Sellers
(last 12 months)
71
Total
Institutional Outflows
(last 12 months)
$93.74M
Get MYGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Myriad Genetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

MYGN Institutional Buying and Selling by Quarter

Myriad Genetics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026Bank of America Corp DE523,020$2.35M0.0%-39.7%0.554%
5/18/2026Amundi27,976$126K0.0%+79.2%0.030%
5/16/2026Quantinno Capital Management LP90,622$408K0.0%+26.8%0.096%
5/16/2026Orbimed Advisors LLC125,000,000$562.50M10.3%N/A132.345%
5/15/2026Weiss Asset Management LP174,844$787K0.0%N/A0.185%
5/14/2026Renaissance Technologies LLC454,374$2.05M0.0%+19.8%0.481%
5/14/2026Public Employees Retirement System of Ohio132,383$596K0.0%-3.7%0.140%
5/14/2026Arrowstreet Capital Limited Partnership204,608$921K0.0%N/A0.217%
5/14/2026Sei Investments Co.45,039$203K0.0%N/A0.048%
5/14/2026State of Wyoming62,664$282K0.0%+134.3%0.066%
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
5/7/2026Dimensional Fund Advisors LP739,051$3.33M0.0%-42.6%0.783%
5/5/2026Bank of New York Mellon Corp334,513$1.51M0.0%-42.5%0.354%
4/30/2026Hsbc Holdings PLC36,331$162K0.0%N/A0.038%
4/27/2026Y Intercept Hong Kong Ltd654,224$2.94M0.1%+83.3%0.693%
4/23/2026Inspire Investing LLC115,726$521K0.0%+28.2%0.123%
4/20/2026OP Asset Management Ltd148,929$670K0.0%N/A0.158%
4/20/2026Assenagon Asset Management S.A.1,446,961$6.51M0.0%+23.9%1.532%
4/16/2026SG Americas Securities LLC51,865$233K0.0%+30.3%0.055%
2/19/2026Invesco Ltd.507,180$3.12M0.0%+2.4%0.544%
2/18/2026Mercer Global Advisors Inc. ADV26,886$165K0.0%+62.7%0.029%
2/18/2026State of Tennessee Department of Treasury36,538$205K0.0%-7.8%0.039%
2/18/2026Vestal Point Capital LP1,223,000$7.52M0.3%+103.8%1.312%
2/18/2026Tudor Investment Corp ET AL44,820$276K0.0%N/A0.048%
2/18/2026Oxford Asset Management LLP23,205$143K0.1%N/A0.025%
2/18/2026Millennium Management LLC6,700,158$41.21M0.0%+41.1%7.188%
2/18/2026Man Group plc81,959$504K0.0%N/A0.088%
2/18/2026Inspire Investing LLC90,271$555K0.0%+13.3%0.097%
2/18/2026Engineers Gate Manager LP64,542$397K0.0%-35.0%0.069%
2/18/2026Balyasny Asset Management L.P.16,155$99K0.0%-88.9%0.017%
2/18/2026Boothbay Fund Management LLC14,163$87K0.0%N/A0.015%
2/17/2026Schonfeld Strategic Advisors LLC95,035$584K0.0%+71.4%0.102%
2/17/2026AQR Capital Management LLC1,870,385$11.50M0.0%+17.1%2.007%
2/17/2026EFG International AG20,983$129K0.0%N/A0.023%
2/17/2026Jain Global LLC188,958$1.16M0.0%+143.9%0.203%
2/17/2026Trexquant Investment LP542,495$3.34M0.0%+35.9%0.582%
2/17/2026Jump Financial LLC168,597$1.04M0.0%+4.3%0.181%
2/17/2026Price T Rowe Associates Inc. MD74,542$459K0.0%+23.7%0.080%
2/17/2026California State Teachers Retirement System89,914$553K0.0%-13.3%0.096%
2/17/2026Russell Investments Group Ltd.167,060$1.03M0.0%-3.5%0.179%
2/17/2026State of Wisconsin Investment Board287,617$1.77M0.0%-3.8%0.309%
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
2/17/2026Captrust Financial Advisors18,044$111K0.0%+26.5%0.019%
2/17/2026ExodusPoint Capital Management LP313,370$1.93M0.0%+1,354.8%0.336%
2/17/2026Royal Bank of Canada4,993$31K0.0%+129.6%0.005%
2/17/2026Graham Capital Management L.P.30,097$185K0.0%N/A0.032%
2/16/2026Squarepoint Ops LLC343,743$2.11M0.0%+190.6%0.369%
2/16/2026Mariner LLC48,166$296K0.0%+68.2%0.052%
2/16/2026Entropy Technologies LP14,300$88K0.0%N/A0.015%
2/16/2026Barclays PLC301,788$1.86M0.0%+4.4%0.324%
2/13/2026Marshall Wace LLP22,302$137K0.0%-53.2%0.024%
2/13/2026The Manufacturers Life Insurance Company 27,495$169K0.0%-10.6%0.029%
2/13/2026CANADA LIFE ASSURANCE Co80,201$493K0.0%-7.4%0.086%
2/13/2026Inspire Advisors LLC26,210$161K0.0%-21.3%0.028%
2/13/2026Walleye Capital LLC677,176$4.17M0.0%+66.8%0.727%
2/13/2026Quarry LP4,365$27K0.0%+155.6%0.005%
2/13/2026Virtus Advisers LLC20,000$123K0.1%N/A0.021%
2/13/2026Jacobs Levy Equity Management Inc.2,270,378$13.96M0.1%-7.1%2.436%
2/13/2026Public Sector Pension Investment Board322,415$1.98M0.0%-11.2%0.346%
2/13/2026Rafferty Asset Management LLC149,229$918K0.0%+32.3%0.160%
2/13/2026Headlands Technologies LLC86,792$534K0.0%+13.6%0.093%
2/13/2026Charles Schwab Investment Management Inc.1,753,711$10.79M0.0%+4.5%1.881%
2/13/2026State Street Corp5,966,567$36.69M0.0%+19.9%6.401%
2/13/2026Ieq Capital LLC228,005$1.40M0.0%+41.1%0.245%
2/13/2026Martingale Asset Management L P128,910$793K0.0%+74.1%0.138%
2/13/2026Dynamic Technology Lab Private Ltd15,883$98K0.0%-60.7%0.017%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC224,133$1.38M0.0%+11.6%0.240%
2/13/2026Wells Fargo & Company MN437,034$2.69M0.0%-14.0%0.469%
2/12/2026Jane Street Group LLC54,417$335K0.0%-75.7%0.058%
2/12/2026HRT Financial LP468,868$2.88M0.0%-40.7%0.503%
2/12/2026MetLife Investment Management LLC42,935$264K0.0%-19.4%0.046%
2/12/2026Renaissance Technologies LLC379,374$2.33M0.0%+1,650.4%0.407%
2/12/2026Dimensional Fund Advisors LP1,287,447$7.92M0.0%-24.1%1.381%
2/12/2026Federated Hermes Inc.1,310,591$8.06M0.0%+16.0%1.406%
2/12/2026Ensign Peak Advisors Inc7,356$45K0.0%-65.5%0.008%
2/12/2026Swiss National Bank183,400$1.13M0.0%+4.0%0.197%
2/12/2026Nuveen LLC1,190,566$7.32M0.0%+64.2%1.277%
2/11/2026Deutsche Bank AG123,183$758K0.0%-69.2%0.132%
2/11/2026Cerity Partners LLC86,475$532K0.0%+8.7%0.093%
2/11/2026Franklin Resources Inc.103,374$636K0.0%+2.7%0.111%
2/11/2026Los Angeles Capital Management LLC97,419$599K0.0%+19.7%0.105%
2/11/2026WINTON GROUP Ltd13,500$83K0.0%N/A0.014%
2/11/2026State of Wyoming26,742$164K0.0%-26.1%0.029%
2/10/2026Goldman Sachs Group Inc.2,160,282$13.29M0.0%+0.4%2.318%
2/10/2026AXQ Capital LP15,691$96K0.0%+37.1%0.017%
2/10/2026Impact Partnership Wealth LLC16,184$100K0.0%+60.1%0.017%
2/10/2026Intech Investment Management LLC228,779$1.41M0.0%+543.3%0.245%
2/9/2026Geode Capital Management LLC2,231,292$13.73M0.0%+0.3%2.394%
2/9/2026Royce & Associates LP605,000$3.72M0.0%-9.7%0.649%
2/9/2026Fisher Asset Management LLC1,207,019$7.42M0.0%-5.6%1.295%
2/6/2026EverSource Wealth Advisors LLC10,469$64K0.0%+139.5%0.011%
2/6/2026GSA Capital Partners LLP187,819$1.16M0.1%N/A0.202%
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
2/5/2026Abacus Wealth Partners LLC13,430$83K0.0%N/A0.014%
1/29/2026Comerica Bank23,922$147K0.0%-17.4%0.026%
1/29/2026Inscription Capital LLC23,372$144K0.0%N/A0.025%
1/29/2026UBS Group AG639,691$3.93M0.0%+29.8%0.686%
1/29/2026Teachers Retirement System of The State of Kentucky22,848$141K0.0%-10.6%0.025%
1/29/2026Vanguard Group Inc.8,225,371$50.59M0.0%+4.3%8.825%
1/26/2026CWM LLC71,774$441K0.0%+13.3%0.077%
1/22/2026Massachusetts Financial Services Co. MA117,436$722K0.0%N/A0.126%
1/21/2026Yousif Capital Management LLC25,523$145K0.0%-12.0%0.027%
1/16/2026Aberdeen Group plc885,801$5.45M0.0%+38.6%0.950%


MYGN Institutional Ownership - Frequently Asked Questions

During the previous two years, 242 institutional investors and hedge funds held shares of Myriad Genetics. The most heavily invested institutionals were Orbimed Advisors LLC ($562.50M), Loomis Sayles & Co. L P ($59.97M), Vanguard Group Inc. ($50.59M), Millennium Management LLC ($41.21M), Wellington Management Group LLP ($40.73M), Artisan Partners Limited Partnership ($37.93M), and State Street Corp ($36.69M).Learn more on Myriad Genetics' institutional investors.

99.02% of Myriad Genetics' stock is owned by institutional investors. Learn more on MYGN's institutional investor holdings.

Of the 210 institutional investors that purchased Myriad Genetics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Orbimed Advisors LLC ($125M), Millennium Management LLC ($1.95M), Nuveen LLC ($1.64M), Assenagon Asset Management S.A. ($1.55M), Jacobs Levy Equity Management Inc. ($1.49M), Connor Clark & Lunn Investment Management Ltd. ($1.37M), and State Street Corp ($1.35M).

Institutional investors have bought a total of 150,029,297 shares in the last 24 months. This purchase volume represents approximately $713.77M in transactions.

Of the 71 institutional investors that sold Myriad Genetics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Disciplined Growth Investors Inc. MN ($3.98M), Bank of America Corp DE ($2.56M), Vanguard Group Inc. ($1.37M), Dimensional Fund Advisors LP ($1.33M), Qube Research & Technologies Ltd ($865.08K), Anson Funds Management LP ($841.94K), and Invesco Ltd. ($427.47K).

Institutional investors have sold a total of 15,707,937 shares in the last 24 months. This volume of shares sold represents approximately $93.74M in transactions.



This page (NASDAQ:MYGN) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners